These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25869258)

  • 41. Endocrine symptoms to predict risk of recurrence?
    Pritchard KI
    Lancet Oncol; 2008 Dec; 9(12):1117-9. PubMed ID: 19038757
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current hormone therapy of prostate cancer].
    Perevodchikova NI; Bukharkin BV
    Vopr Onkol; 1996; 42(4):7-11. PubMed ID: 8928465
    [No Abstract]   [Full Text] [Related]  

  • 43. New treatment for advanced prostate cancer.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101352
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evolution of endocrine therapy for prostate cancer].
    Igawa T; Saito Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():176-81. PubMed ID: 11022709
    [No Abstract]   [Full Text] [Related]  

  • 45. Open to debate. The motion: Hormonal blockade should be limited due to significant adverse effects.
    Boccon-Gibod L; Tombal B
    Eur Urol; 2009 Jan; 55(1):240-3. PubMed ID: 18930581
    [No Abstract]   [Full Text] [Related]  

  • 46. Editorial: hormone therapies for prostate cancer--acute disease control, chronic disease progression.
    Lamb DJ; Buttyan R
    J Urol; 2003 Apr; 169(4):1558. PubMed ID: 12629414
    [No Abstract]   [Full Text] [Related]  

  • 47. Will GnRH antagonists improve prostate cancer treatment?
    Huhtaniemi I; White R; McArdle CA; Persson BE
    Trends Endocrinol Metab; 2009 Jan; 20(1):43-50. PubMed ID: 19008119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New development of endocrine therapy in prostate cancer].
    Naito S
    Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer.
    Boccon-Gibod L; Iversen P; Persson BE
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1737-43. PubMed ID: 19954284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Putting evidence into practice: evidence-based interventions for hot flashes resulting from cancer therapies.
    Kaplan M; Mahon S; Cope D; Keating E; Hill S; Jacobson M
    Clin J Oncol Nurs; 2011 Apr; 15(2):149-57. PubMed ID: 21444282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormonal intervention in breast cancer. Past, present, and future.
    Osborne MP
    Ann N Y Acad Sci; 1996 Apr; 784():427-32. PubMed ID: 8651592
    [No Abstract]   [Full Text] [Related]  

  • 52. [Quality of life of patients with prostatic cancer under hormonal therapy].
    Aliaev IuG; Aslamazov EG; Demidko IuL
    Urologiia; 2010; (1):46, 48-51. PubMed ID: 20891045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormonal therapy for prostate cancer in men with heart disease.
    Agarwal N
    JAMA; 2010 Jan; 303(1):32-3; author reply 33. PubMed ID: 20051564
    [No Abstract]   [Full Text] [Related]  

  • 54. Presurgical (neoadjuvant) endocrine therapy is a useful model to predict response and outcome to endocrine treatment in breast cancer patients.
    Geisler J; Smith I; Miller W
    J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):93-100. PubMed ID: 22207086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Histological investigation of prostate cancer treated with hormonal agents].
    Azumi M; Saga Y; Hashimoto H; Kakizaki H
    Hinyokika Kiyo; 2006 Oct; 52(10):781-4. PubMed ID: 17131867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate cancer: Combining endocrine treatment and radiotherapy: a bright future.
    Roach M
    Nat Rev Urol; 2016 Jul; 13(7):373-4. PubMed ID: 27245503
    [No Abstract]   [Full Text] [Related]  

  • 57. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
    Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
    Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review of interventions to improve adherence to endocrine therapy.
    Heiney SP; Parker PD; Felder TM; Adams SA; Omofuma OO; Hulett JM
    Breast Cancer Res Treat; 2019 Feb; 173(3):499-510. PubMed ID: 30387003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormonal treatment of breast cancer. Implications for quality of life, communication and improved therapy].
    Denton S
    Oncologica; 1996 Feb; 13(1):18-20. PubMed ID: 9516751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.